Orntoft TF - Search Results

1

Molecular alterations in bladder cancer.

Orntoft TF, Wolf H. Orntoft TF, et al. Urol Res. 1998;26(4):223-33. doi: 10.1007/s002400050050. Urol Res. 1998. PMID: 9759995 Review.

2

Allelic imbalances in human bladder cancer: genome-wide detection with high-density single-nucleotide polymorphism arrays.

Primdahl H, Wikman FP, von der Maase H, Zhou XG, Wolf H, Orntoft TF. Primdahl H, et al. Among authors: orntoft tf. J Natl Cancer Inst. 2002 Feb 6;94(3):216-23. doi: 10.1093/jnci/94.3.216. J Natl Cancer Inst. 2002. PMID: 11830611

3

Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancer.

Primdahl H, von der Maase H, Sørensen FB, Wolf H, Ørntoft TF. Primdahl H, et al. Among authors: orntoft tf. J Cancer Res Clin Oncol. 2002 Jun;128(6):295-301. doi: 10.1007/s00432-002-0344-3. Epub 2002 Apr 27. J Cancer Res Clin Oncol. 2002. PMID: 12073046

4

Activity of the human blood group ABO, Se, H, Le, and X gene-encoded glycosyltransferases in normal and malignant bladder urothelium.

Orntoft TF, Wolf H, Watkins WM. Orntoft TF, et al. Cancer Res. 1988 Aug 1;48(15):4427-33. Cancer Res. 1988. PMID: 3134126

5

Blood group ABO and Lewis antigens in bladder tumors: correlation between glycosyltransferase activity and antigen expression.

Orntoft TF, Wolf H. Orntoft TF, et al. APMIS Suppl. 1988;4:126-33. APMIS Suppl. 1988. PMID: 3146987

6

Loss of ABH antigen expression in bladder cancer is not caused by loss of heterozygosity of the ABO locus.

Meldgaard P, Johnson PH, Langkilde NC, Wolf H, Orntoft TF. Meldgaard P, et al. Among authors: orntoft tf. Int J Cancer. 1995 Nov 3;63(3):341-4. doi: 10.1002/ijc.2910630306. Int J Cancer. 1995. PMID: 7591228

7

The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines.

Orntoft TF, Meldgaard P, Pedersen B, Wolf H. Orntoft TF, et al. Cancer Res. 1996 Mar 1;56(5):1031-36. Cancer Res. 1996. PMID: 8640757

8

Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas.

Celis JE, Ostergaard M, Basse B, Celis A, Lauridsen JB, Ratz GP, Andersen I, Hein B, Wolf H, Orntoft TF, Rasmussen HH. Celis JE, et al. Among authors: orntoft tf. Cancer Res. 1996 Oct 15;56(20):4782-90. Cancer Res. 1996. PMID: 8840999

9

Increased concentrations of genotype-interpreted Ca 19-9 in urine of bladder cancer patients mark diffuse atypia of the urothelium.

Vestergaard EM, Wolf H, Orntoft TF. Vestergaard EM, et al. Among authors: orntoft tf. Clin Chem. 1998 Feb;44(2):197-204. Clin Chem. 1998. PMID: 9474011

10

Pronounced microsatellite instability in transitional cell carcinomas from young patients with bladder cancer.

Christensen M, Jensen MA, Wolf H, Orntoft TF. Christensen M, et al. Among authors: orntoft tf. Int J Cancer. 1998 Aug 21;79(4):396-401. doi: 10.1002/(sici)1097-0215(19980821)79:4<396::aid-ijc15>3.0.co;2-3. Int J Cancer. 1998. PMID: 9699533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters